Skip to main content

Table 2 Characteristics of the samples used in the analyses

From: Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries

 

Child sample (N = 92)

Adolescent sample (N = 110)

Adult sample (N = 104)

Parent samplea (N = 253)

Young Children sampleb (N = 52)

Age (years)

n (missing)

90 (2)

110 (0)

101 (3)

244 (9)

52 (0)

Mean (SD)

9.8 (0.8)

14.5 (1.6)

25.8 (6.6)

41.6 (6.5)

4.4 (2.5)

Min – Max

9.0–11.0

12.0–17.0

18.0–45.0

24.0–66.0

0.0–8.0

Gender

Male

43 (46.7)

56 (50.9)

38 (36.5)

69 (27.3)

28 (53.8)

n (%)

 

Female

47 (51.1)

54 (49.1)

66 (63.5)

183 (72.3)

24 (46.2)

 

Missing

2 (2.2)

0 (0.0)

0 (0.0)

1 (0.4)

0 (0.0)

Treated with BH4

n (%)

27 (29.3)

27 (24.5)

15 (14.4)

–

13 (25.0)

PKU severity

Classicalc

66 (71.7)

75 (68.2)

67(64.4)

–

32 (61.5)

n (%)

Missing

4 (4.3)

2 (1.8)

0 (0.0)

–

0 (0.0)

Management

Medical only

45 (48.9)

49 (44.5)

39 (37.5)

–

21 (40.4)

n (%)

Multi-disciplinary team

45 (48.9)

61 (55.5)

63 (60.6)

–

31 (59.6)

Missing

2 (2.2)

0 (0.0)

0 (0.0)

–

0 (0.0)

Overall health status rating by clinician

Poor

0 (0.0)

0 (0.0)

0 (0.0)

–

0 (0.0)

Fair

2 (2.1)

0 (0.0)

3 (2.9)

–

0 (0.0)

n (%)

Good

19 (20.7)

38 (34.5)

28 (26.9)

–

7 (13.5)

Very good

41 (44.6)

42 (38.2)

46 (44.2)

–

18 (34.6)

Excellent

28 (30.4)

30 (27.3)

26 (25.0)

–

27 (51.9)

Missing

2 (2.2)

0 (0.0)

1 (1.0)

–

0 (0.0)

Country

France

13 (14.1)

10 (9.1)

18 (17.3)

33 (13.0)

10 (19.2)

n (%)

Germany

19 (20.7)

20 (18.2)

21 (20.2)

46 (18.2)

8 (15.4)

Italy

15 (16.3)

26 (23.6)

22 (21.2)

49 (19.4)

8 (15.4)

Netherlands

7 (7.6)

10 (9.1)

7 (6.7)

23 (9.1)

6 (11.5)

Spain

20 (21.7)

20 (18.2)

21 (20.2)

48 (19.0)

8 (15.4)

Turkey

14 (15.2)

20 (18.2)

8 (7.7)

40 (15.8)

6 (11.5)

UK

4 (4.3)

4 (3.6)

7 (6.7)

14 (5.5)

6 (11.5)

Missing

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

  1. SD standard deviation
  2. aData for the Parent sample relate to the parent and not the children; hence characteristics related to disease are not reported
  3. bChildren with PKU younger than eight years old for whom a parent-completed PKU-QOL was collected
  4. cClassical PKU defined as Phe level at diagnosis >1200 μmol/L